Herndon Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | $20.8M | Sell |
293,842
-20,073
| -6% | -$1.42M | 3.16% | 4 |
|
2017
Q1 | $21.3M | Buy |
313,915
+74,417
| +31% | +$5.05M | 3.11% | 3 |
|
2016
Q4 | $17.2M | Sell |
239,498
-180,677
| -43% | -$12.9M | 2.27% | 23 |
|
2016
Q3 | $33.2M | Sell |
420,175
-150,465
| -26% | -$11.9M | 1.66% | 34 |
|
2016
Q2 | $47.6M | Sell |
570,640
-308,664
| -35% | -$25.7M | 1.83% | 31 |
|
2016
Q1 | $80.8M | Sell |
879,304
-136,282
| -13% | -$12.5M | 2.02% | 29 |
|
2015
Q4 | $103M | Sell |
1,015,586
-88,435
| -8% | -$8.95M | 2.17% | 28 |
|
2015
Q3 | $108M | Sell |
1,104,021
-93,176
| -8% | -$9.15M | 2.11% | 25 |
|
2015
Q2 | $140M | Sell |
1,197,197
-128,001
| -10% | -$15M | 2.33% | 24 |
|
2015
Q1 | $130M | Sell |
1,325,198
-152,750
| -10% | -$15M | 1.94% | 33 |
|
2014
Q4 | $139M | Sell |
1,477,948
-331,338
| -18% | -$31.2M | 1.9% | 32 |
|
2014
Q3 | $194M | Buy |
1,809,286
+795,250
| +78% | +$85.4M | 2.56% | 9 |
|
2014
Q2 | $84.1M | Buy |
+1,014,036
| New | +$84.1M | 1.05% | 45 |
|
2013
Q3 | – | Sell |
-105,459
| Closed | -$5.41M | – | 186 |
|
2013
Q2 | $5.41M | Buy |
+105,459
| New | +$5.41M | 0.08% | 63 |
|